共 157 条
[11]
Colombo A(2020)Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998–2016 Acta Oncol 59 549-557
[12]
Henry A(2020)Benefits and risks of primary treatments for high-risk localized and locally advanced prostate cancer: an international multidisciplinary systematic review Eur Urol 103 395-404
[13]
Yamada Y(2017)Understanding urinary toxicity after radiotherapy for prostate cancer: first steps forward Tumori J 57 1003-1010
[14]
Rogers L(2018)Genitourinary and gastrointestinal toxicity among patients with localized prostate cancer treated with conventional versus moderately hypofractionated radiation therapy: systematic review and meta-analysis Acta Oncol 75 464-476
[15]
Demanes DJ(2019)Pelvic complications after prostate cancer radiation therapy and their management: an international collaborative narrative review Eur Urol 31 1257-1280
[16]
Davis BJ(1995)The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy Internat J Radiat Oncol Biol Phys 29 517-523
[17]
Horwitz EM(2006)The role of α-blockers in the management of lower urinary tract symptoms in prostate cancer patients treated with radiation therapy Am J Clin Oncol 110 304-325
[18]
Lee WR(2012)Posterior urethral complications of the treatment of prostate cancer BJU Internat 47 852-861
[19]
Zelefsky MJ(2009)Patient-reported lower urinary tract symptoms, urinary incontinence, and quality of life after external beam radiotherapy for localized prostate cancer – 15 years’ follow-up. A comparison with age-matched controls Acta Oncol 11 1925-1931
[20]
Cowen D(2014)Challenges and choices in prostate cancer irradiation: from the three dimensional conformal radiotherapy to the era of intensity modulated, image-guided and adaptive radiation treatment Urol J 62 255-259